Ausio header



Ausio’s management team has more than 50 years combined product development experience. This team has been instrumental in the development of more than 100 pharmaceutical products, some of which are first-in-class products.




President and CEO


Jeff Courtney has more than 25 years' experience in business and finance with Ernst & Young, Village Roadshow Limited, Mayne Pharma Group, Sanitarium Health & Wellbeing Limited and Asklepion Pharmaceuticals. He currently sits on numerous pharmaceutical company boards in North America.




Vice President, Regulatory Affairs



Dr. Schwen is Vice President of Regulatory Affairs at Ausio Pharmaceuticals.  After receiving his PhD in pharmacology from the University of Minnesota, Dr. Schwen joined Procter and Gamble’s drug research organization as a Toxicologist, later moving into positions in drug discovery and regulatory affairs.  Since then Dr. Schwen has held senior management positions at Kendle International (Vice President of Global Regulatory, Safety and Clinical Quality Assurance), Parexel International (Vice President of Regulatory Affairs/Americas), and Strategic Regulatory Consulting (Vice President, Safety and Regulatory Affairs).  Dr. Schwen is an Adjunct Professor at the University of Cincinnati College of Pharmacy, is board certified in toxicology and regulatory affairs, and serves as chair of the Cincinnati Board of Health.




Director of Clinical Development


Dr. Greiwe is Director of Clinical Development at Ausio Pharmaceuticals, LLC.  After graduating from Indiana University, he received a MS degree from Ball State University and a PhD from Southern Illinois University.  He completed his post-doctoral training at Washington University School of Medicine.  Prior to joining Ausio Pharmaceuticals, Dr. Greiwe held positions at Medpace, Xanodyne Pharmaceuticals and LBR Regulatory and Clinical Consulting Services.

Home Contact UsDirections